Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Landmark approval for pancreatic cancer; Reactions to Lilly’s Phase 1 secrecy; and more

Welcome back to Endpoints Weekly! The big news this week was the FDA’s approval of Revolution Medicines’ pancreatic cancer treatment Rasonque. The drug stunned researchers and spurred excitement in April, when it nearly doubled patients’ ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Saturday 29 August →